Abstract
The global incidence of sickle cell disease (SCD) is 20-25 million people, being more common in certain ethnic groups, such as African descent. Its clinical manifestations are heterogeneous and its therapeutic management is complex. Recently, the scientific community has shown interest in the possible correlation of SCD with statins. Recent studies have shown that, through still unknown m…